Replies to post #253 on InMed Pharmaceuticals Inc (INM)

[MonestHind]

Yeah every stock recommended has plummeted severely. Subscribers have lost a ton of money. Now it seems that no one will touch any stock recommended by that service. After multiple halts and 75% losses, I don't blame'em.

Hopefully you're right about this one.